Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

Marc K. Wallack, Muthukumaran Sivanandham, Charles M. Balch, Marshall M. Urist, Kirby I. Bland, Douglas Murray, William A. Robinson, Lawrence Flaherty, Jon M. Richards, Alfred A. Bartolucci, Les Rosen

Research output: Contribution to journal › Article › peer-review

162 Scopus citations

Fingerprint

Dive into the research topics of 'Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial'. Together they form a unique fingerprint.

Medicine & Life Sciences